Transcode Therapeutics Inc. (RNAZ)
Market Closed
15 Oct, 08:00 PM
NASDAQ (CM) NASDAQ (CM) Primary $
1. 80
+0.07
+4.0462%
Pre Market
$
+0.1 +5.5556% 1. 90
1.97M Market Cap
- P/E Ratio
- Div Yield
34,589 Volume
-2.14 Eps
$ 1.73
Previous Close Want to track RNAZ and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Transcode Therapeutics Inc. (RNAZ) Statistics
Valuation metrics
Market Cap 1.97M
Enterprise value -5.76M
Trailing P/E (ttm) -0.04
Forward P/E -
PEG ratio -0
Price/Sales (ttm) -
Price/Book (mrq) 0.01
Enterprise Value/Revenue -
Enterprise Value/EBITDA 0.14
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 34.77K
Average volume (90 days) 52.38K
Price summary
52-Week low 1.52
52-Week high 15.39
Beta -
50-Day moving average 1.89
200-Day moving average 5.26
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -40.33
Dividend Date -
Ex-Dividend Date -
Last split factor 1:28
Last split Date 15 May 2025
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -
Operating margin -
Operational effectiveness
Return on assets -0.28%
Return on equity -0.58%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) -
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -45.65
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 8.95
Total debt (mrq) -
Total Debt/Equity (mrq) 0
Current ratio (mrq) 1.97%
Book value per share (mrq) 147.63
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
2026 © Marketlog. All Rights Reserved.
